Biological treatment in multiple sclerosis. Review current development

Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 10

Abstract

Multiple sclerosis (MS) is autoimmunological disorders of central nerves system (cns). Results of damage in cns cause by disease are serious deficits in different fields of human activities, also mental and in the end very heavy disability of people suffer from disease. We focus in treatment, especially in relapsing – remitting form of MS, on the protection of axon damage which causes progress of disease and disability, and finally life shortens in effect of disease. Currently we observe very rapid progress thanks of new discoveries of factors playing important role in mechanism of disease and development of pharmacology created new products able to modifying pathological activity of immunological system in cns. These medicines affect on different levels of pathological processes, within equal cns as well as besides it. This progress includes creation of new forceful medicines not only more effectivness, but it includes new, oral forms of medicines that makes considerable correction of comfort of treatment. Diversity of new medicine allows to employ principle of personation of treatment more forcefully. Additonally we can many times select and modify treatment depending on efficiency. Unfortunately we observed the major progress in the treatment of relapsing-remitting multiple sclerosis and in contrast we still have problems in treatment of primary progressive multiple sclerosis (PPMS). All clinical trials have failed and there is limited evidence of their efficacy in secondary progressive disease.

Authors and Affiliations

Witold Palasik

Keywords

Related Articles

Behavioral management of pain in children and adolescents

The purpose of this paper is to discuss the behavioral techniques of pain management used in clinical practice in children and adolescents and to review the results of studies aimed at assessing their effectiveness. The...

Can Interferon-Gamma Release Assays be helpful for the diagnosis of pulmonary and extrapulmonary tuberculosis?

The diagnosis of pulmonary tuberculosis and tuberculous pleurisy standard methods is difficult and slow. Now, high hopes to cells of T cells secreting interferon-gamma in response to antigens of Mycobacterium tuberculosi...

Bóle stawów u osób w wieku podeszłym

Bóle stawów często dotyczą ludzi w podeszłym wieku. Ich główne przyczyny to: choroba zwyrodnieniowa, zapalne choroby tkanki łącznej (polimialgia reumatyczna, olbrzymiokomórkowe zapalenie tętnic, chondrokalcynoza, choroba...

Vascular complications after cardiac invasive procedures – diagnosis and management

Arterial puncture is related with the risk of bleeding and site complications. Therefore this procedure should be performed by physicians. Vascular complications present an important problem in contemporary invasive card...

Biosynthesis, post-translational modifications, maturation, and physiological function of human thyroid peroxidase

Apart from being the major target autoantigen in autoimmune thyroid disease, thyroid peroxidase (TPO) is the key enzyme, together with DUOX proteins, responsible for the thyroid hormone generation. Newly synthesized TPO...

Download PDF file
  • EP ID EP54584
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Witold Palasik (2013). Biological treatment in multiple sclerosis. Review current development. Postępy Nauk Medycznych, 26(10), -. https://europub.co.uk/articles/-A-54584